At the European Association for the Study of Diabetes meeting, Louis J. Aronne, MD, argued that obesity medications could make bariatric surgery obsolete, thanks to drugs that treat multiple metabolic conditions. Francesco Rubino, MD, countered, suggesting “metabolic” surgery will continue to play a key role, especially for long-term management of obesity and related conditions. Aronne believes future treatments will address obesity earlier, while Rubino sees surgery remaining important for certain patients. Both agree obesity management is evolving rapidly.
Trending
- SAGA Diagnostics® Launches Ultrasensitive Pathlight™ MRD Test in Colorectal Cancer (Business Wire)
- Task force updates ERCP quality metrics (GI & Hepatology News)
- New simulator mimics real tissue for safer endoscopic cancer surgery training (Medical Xpress)
- 5 GI leaders on what’s changing in colonoscopy (Becker’s GI & Endoscopy)
- Scientists create a luminous pill with biosensors meant to replace colonoscopies (Earth.com)
- FUJIFILM 800 Series Duodenoscopes Now Compatible with CE Mark Approved ULTRA GI Cycle (Fujifilm)
- Private Equity’s Healthcare Boom Is Getting More Crowded (MedCity News)
- Nvidia, Eli Lilly to spend $1 billion over five years on joint research lab (Reuters)
